OGN logo

Organon & Co (OGN) Company Overview

Profile

Full Name:

Organon & Co.

Sector:

Healthcare

Country:

United States

IPO:

May 14, 2021

Indexes:

Not included

Description:

Organon & Co is a global healthcare company focused on women's health, biosimilars, and other medicines. They develop and provide treatments for various health issues, aiming to improve the lives of women and patients worldwide. Their mission is to empower people to live healthier lives.

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 24, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Barclays
Overweight
Sep 6, 24 JP Morgan
Underweight
May 6, 24 Goldman Sachs
Neutral
May 3, 24 Goldman Sachs
Neutral
Apr 29, 24 Piper Sandler
Overweight
Feb 20, 24 Goldman Sachs
Neutral
Nov 22, 23 Piper Sandler
Overweight
Nov 3, 23 Goldman Sachs
Neutral
Oct 25, 23 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Organon & Co?
  • Does Organon & Co pay dividends?
  • What sector is Organon & Co in?
  • What industry is Organon & Co in?
  • What country is Organon & Co based in?
  • When did Organon & Co go public?
  • Is Organon & Co in the S&P 500?
  • Is Organon & Co in the NASDAQ 100?
  • Is Organon & Co in the Dow Jones?
  • When was Organon & Co's last earnings report?
  • When does Organon & Co report earnings?
  • Should I buy Organon & Co stock now?

What is the ticker symbol for Organon & Co?

The ticker symbol for Organon & Co is NYSE:OGN

Does Organon & Co pay dividends?

Yes, Organon & Co pays dividends. The last payment was $0.28, with an ex-dividend date on February 24, 2025

What sector is Organon & Co in?

Organon & Co is in the Healthcare sector

What industry is Organon & Co in?

Organon & Co is in the Drug Manufacturers - General industry

What country is Organon & Co based in?

Organon & Co is headquartered in United States

When did Organon & Co go public?

Organon & Co's initial public offering (IPO) was on May 14, 2021

Is Organon & Co in the S&P 500?

No, Organon & Co is not included in the S&P 500 index

Is Organon & Co in the NASDAQ 100?

No, Organon & Co is not included in the NASDAQ 100 index

Is Organon & Co in the Dow Jones?

No, Organon & Co is not included in the Dow Jones index

When was Organon & Co's last earnings report?

Organon & Co's most recent earnings report was on Feb 13, 2025

When does Organon & Co report earnings?

The next expected earnings date for Organon & Co is May 2, 2025

Should I buy Organon & Co stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions